Glostrup, Denmark

Jørgen Scheel-Kruger


Average Co-Inventor Count = 4.8

ph-index = 1


Location History:

  • Glostrup, DE (2007)
  • Glostrup, DK (2011)

Company Filing History:


Years Active: 2007-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Jørgen Scheel-Kruger

Introduction

Jørgen Scheel-Kruger is an innovative inventor based in Glostrup, Denmark. With a focus on pharmaceutical applications, he has made significant contributions to the development of neurotransmitter re-uptake inhibitors. His unique perspective and expertise have led to the creation of two noteworthy patents that aim to improve therapeutic options in the medical field.

Latest Patents

Jørgen’s latest patents include:

1. **Alkyl Substituted Homopiperazine Derivatives**

This invention relates to novel alkyl substituted homopiperazine derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In addition, the invention discusses the use of these compounds in therapeutic methods and pharmaceutical compositions containing them.

2. **8-Aza-Bicyclo[3.2.1]Octane Derivatives**

Similar to his first patent, this invention focuses on novel 8-aza-bicyclo[3.2.1]octane derivatives that serve as monoamine neurotransmitter re-uptake inhibitors. The implications of this invention extend to the utilization of these compounds in therapy and the integration into pharmaceutical compositions.

Career Highlights

Jørgen Scheel-Kruger works at Neurosearch A/S, a company dedicated to advancing treatments through innovative research. His contributions have played a vital role in enhancing the therapeutic landscape for mental health and neurological disorders.

Collaborations

Throughout his career, Jørgen has collaborated with esteemed colleagues, including Dan Peters and Gunnar M. Olsen. These partnerships highlight the collaborative spirit within the field, driving forward inventive solutions to complex medical challenges.

Conclusion

Jørgen Scheel-Kruger exemplifies the innovative spirit of modern inventors, with his contributions to neurotransmitter re-uptake inhibitors marking a significant step forward in pharmaceutical sciences. His work at Neurosearch A/S and collaborations with peers further enrich the development of effective therapies, ensuring that his inventions have a lasting impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…